Latest Headlines

  1. Ambry Genetics Announces One Millionth Test Leveraging RNA To Improve Diagnostic Accuracy And Yield 2/2/2026

    Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. announced the completion of its one-millionth DNA/RNA test, underscoring the company’s commitment to diagnostic accuracy.

  2. Aiforia Releases A New CE-IVD Marked AI Solution For Gastric Cancer Diagnostics 2/2/2026

    Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia Gastric Cancer AI application is designed to support pathologists in the detection and reporting of gastric cancer in digitized gastric tissue samples.

  3. Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test For Myeloma, Enabling Ultrasensitive Detection Of Residual Disease 2/2/2026
  4. Lumea And Voicebrook Announce Strategic Partnership To Advance Digital Pathology Workflows 1/30/2026

    Lumea, the leading provider of innovative tissue handling and digital diagnostic technologies, today announced a strategic digital pathology partnership with Voicebrook, the leading provider of pathology reporting solutions.

  5. Renew Biotechnologies Advances Epigenetic Diagnostics Through Launch Of Path Fertility's NOA Guide 1/29/2026

    Renew Biotechnologies (Renew) today announced its role as the clinical testing provider for Path Fertility's NOA Guide, a newly launched epigenetic diagnostic test designed to inform surgical decision-making for men with non-obstructive azoospermia (NOA), a form of male infertility.

  6. Slope And LabConnect Expand Partnership Momentum With Multiple API-Integrated Clinical Trials Launched In Q4 2025 1/29/2026

    Slope, the only end-to-end, vendor-agnostic platform for managing biospecimens and lab kits, and LabConnect, a premier provider of technology-driven, global central laboratory solutions, today announced major momentum in their partnership following the launch of their API integration last year.

  7. Beckman Coulter Life Sciences Partners With Automata To Accelerate AI-Ready Laboratory Automation 1/29/2026

    Beckman Coulter Life Sciences and Automata today announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata’s AI-ready automation platform to enable faster, more consistent and more scalable experimentation for research organizations.

  8. Low Binding DNA Consumables For NGS And Molecular Biology 1/29/2026

    Azenta Life Sciences offers a range of low binding consumables that deliver consistent performance from sensitive applications that require low DNA input such as Next Generation Sequencing (NGS).

  9. Labcorp Collaborates With Roche To Bring Fully Automated Mass Spectrometry To U.S. Clinical Labs 1/28/2026

    Labcorp a global leader of innovative and comprehensive laboratory services, announced today that it is the first U.S. commercial laboratory with an agreement to implement Roche’s cobas Mass Spec solution.

  10. Olympus Announces U.S. Launch Of The SecureFlex™ Single-Use Fine Needle Biopsy Device 1/28/2026

    Olympus Corp. of the Americas, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, announced today the U.S. launch of its most advanced single-use fine needle biopsy device used in ultrasound-guided tissue sampling for the diagnosis of diseases such as pancreatic cancer.